iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
1.670
+0.080 (5.03%)
At close: Jun 26, 2026, 4:00 PM EDT
1.665
-0.005 (-0.31%)
After-hours: Jun 26, 2026, 7:58 PM EDT
iBio, Inc. Employees
iBio, Inc. had 20 employees as of June 30, 2025. The number of employees increased by 4 or 25.00% compared to the previous year.
Employees
20
Change (1Y)
4
Growth (1Y)
25.00%
Revenue / Employee
$15,000
Profits / Employee
-$1,380,300
Market Cap
82.96M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Gossamer Bio | 162 |
| Heron Therapeutics | 128 |
| MindWalk Holdings | 102 |
| Adicet Bio | 102 |
| Cardiff Oncology | 31 |
| LeonaBio | 19 |
| Rallybio | 14 |
| MAIA Biotechnology | 13 |
IBIO News
- 19 days ago - iBio initiated with an Outperform at Raymond James - TheFly
- 23 days ago - iBio, Inc. Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 25 days ago - iBio to Participate in Upcoming Healthcare Investor Conferences - GlobeNewsWire
- 25 days ago - iBio doses first participant in IBIO-600 trial - TheFly
- 25 days ago - iBio Becomes a Clinical-Stage Company with First Participant Dosed in Phase 1 Clinical Trial of IBIO-600 in Adults with Obesity - GlobeNewsWire
- 6 weeks ago - iBio, Inc. Slides: Corporate presentation - Filings
- 6 weeks ago - iBio reports Q3 EPS (7c), consensus (6c) - TheFly
- 6 weeks ago - iBio Reports Q3 Fiscal Year 2026 Financial Results and Provides Corporate Update - GlobeNewsWire